"Although there has not been a jump in adverse events from SSRIs, there has been community concern about potential overuse," said the TGA
Medicare stats show that, since 1990, when Prozac first was on pharmacy shelves, there have been almost 10,000 reports of suspected adverse reactions to SSRIs.
Over 12 million SSRI antidepressant scripts were subsidized by the Pharmaceutical Benefits Scheme last year.
psychiatrist Yolande Lucire, has reported between 300 and 400 cases to the TGA which she claims patients have had serious reactions to the anti-depressants, a few who had committed suicide. This inquiry must be made public.
"This is being done in secret. We have no terms of reference, no opportunity for people to make submissions; it's a scandal." Says Dr.Lucire
Federal Health Department secretary Jane Halton wrote to Dr Lucire telling her that her inquiry was under way and the panel would report back to her at the end of this year.
"This only happened after," Dr Lucire said. "In frustration at being fobbed off by the TGA, I personally sent the head of the department 100 cases detailing what had actually happened to people who went from being fully functioning members of the community to patients with serious mental health problems and some who in fact killed themselves after being put on these drugs for stress-related disorders."
The TGA asked all drug companies that market SSRI anti-depressants in Australia to update the wording of their suicide warnings concerning children and young people under 24 years.
investigation revealed several hundred thousand prescriptions for anti-depressants like Zoloft and Prozac were last year prescribed to children and subsidized through the Pharmaceutical Benefits Scheme, despite the TGA and Pfizer, the company that markets Zoloft in Australia, recommending they not be prescribed to anyone under the age of 24.
Significant discrepancies in the information given to parents about the potential dangers of the drugs to children were also uncovered.
Two weeks ago, Melbourne mother reached a confidential court settlement with her 16-year-old daughter's GP, who she had sued for prescribing Zoloft to her daughter for depression.
Mulcahey claimed the drug made her daughter suicidal and said she was not advised of the risks.
In another case a 14-year-old girl became suicidal after taking Zoloft. Her parents said they were not warned this might happen nor told to monitor her for symptoms of suicidal thoughts or self-harm.
"But in the general setting I would say that nothing new in the literature suggests we need to be any more vigilant than we already have been when it comes to documenting the side effects of this class of drug," Dr Kitching said.

